AKRX News and Press, Akorn Inc.

Akorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg PR Newswire GURNEE, Ill. , Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic v...

A coalition of 51 attorneys general in the U.S. has filed an antitrust complaint  in federal court against 26 companies making generic dermatology drugs and 10 executives at these firms claiming wide-spread price-fixing, marketing allocating and bid-rigging related to over 80 different...

Note: I have covered Akorn Inc. ( AKRX ) previously, so investors should view this as an update to my earlier article on the company. As expected, and previously outlined in many of its public disclosures, generic pharmaceuticals manufacturer Akorn Inc. finally filed for Chapter 11 ...

Akorn (NASDAQ: AKRX ) drops  25%  premarket in reaction to its filing for voluntary protection under Chapter 11 of the U.S. Bankruptcy Code to execute an in‑court sale of its business while addressing litigation-related overhangs. More news on: Akorn, Inc., Healthca...

LAKE FOREST, Ill. , May 20, 2020 /PRNewswire/ -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company ("Akorn" or the "Company"), today announced that the Company and its U.S. subsidiaries filed for voluntary protection under Chapter 11 ("Chapter 11") of the U.S. Bankrup...

Editor's note: Seeking Alpha is proud to welcome Noah Riley as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA PREMIUM. Click here to find out more » I believe that Akorn i...

Are These On Your List Of Penny Stocks To Watch This Week? It can be tough at times to trade penny stocks . Some days there are only a few names to choose from. But there are other days where there seems to be plenty of penny stocks to buy . In either case, having your plan in place can defi...

Akorn (NASDAQ: AKRX ): Q1 EPS of $0.36 may not be comparable to consensus of -$0.09. More news on: Akorn, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

LAKE FOREST, Ill., May 11, 2020 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the first quarter of 2020. First Quarter 2020 Results and Recent Developments Net revenue was $205 million, up $39 mi...

Are These On Your List Of Penny Stocks to Watch Today? Penny stocks have been some of the best performers this year. Thanks in part to the coronavirus, cheap stocks have gone on to become industry competitors. Whether it is from the testing side or the vaccine niche, biotech penny stocks hav...